Not provided
Not provided
Not provided
Not provided
Not provided
Departure of Chief Investigator/Principal Investigator
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The long saphenous vein is traditionally harvested for use as a conduit in coronary artery bypass grafting surgery. Currently, the long saphenous vein is not imaged prior to surgery. This study aims to evaluate preoperative ultrasound mapping of the long saphenous vein to to improve patient and clinical outcomes.
A vein from the leg is widely is widely harvested during coronary artery bypass grafting (CABG) surgery for bypass of diseased coronary arteries. This vein is called the long saphenous vein.
Currently, the long saphenous vein (LSV) is harvested blind by surgical practitioners with no imaging prior to surgery to decide on whether this vein is suitable for use in heart bypass surgery. This can result in fruitless incisions and result in additional unnecessary surgical wounds in the leg(s) to identify a suitable section of vein that can be used in the bypass operation. In these cases, excessive surgical trauma to the leg can increase the risk of a wound infection.
There is some evidence that ultrasound imaging of the LSV improves leg wound outcomes in patients having CABG surgery. Some studies have reported reductions in vein wound infection rates, vein harvest time, length of hospitalisation and length of wounds.
The purpose of this study will be to investigate the potential benefit of ultrasound imaging as a randomised control trial. One group will have ultrasound imaging of the long saphenous vein prior to heart bypass surgery. A second group will not undergo ultrasound imaging which is current practice at the Bristol Heart Institute.
Ultrasound imaging of the long saphenous vein will allow planning and selection of the most optimal segment of vein. This targeted approach will allow guidance of surgical incisions away from unsuitable segments and thus potentially improving leg wound outcomes.
The primary endpoint for this study will be to assess leg wound infection between the two randomised groups. Other endpoints that will be assessed are patient satisfaction, wound length, time taken to remove the vein, blood loss from the leg wound during surgery and the number of wounds in your leg.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pre-operative ultrasound imaging | Experimental | Subjects that are randomly allocated to this group will have ultrasound imaging assessment of the long saphenous vein in both legs. This will allow assessment of the suitability of the long saphenous vein and marking of the distribution prior to heart bypass surgery to allow targeted harvesting of a bypass conduit. |
|
| Current protocol | No Intervention | This group will not undergo pre-operative ultrasound imaging of the long saphenous vein in accordance with current Trust protocols. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ultrasound imaging of the long saphenous vein | Procedure | Ultrasound imaging of the long saphenous vein from the ankle to the saphenofemoral junction. This will allow assessment of vein calibre, branches and bifurcations, presence of thrombophlebitis and distribution. The presence of a proximal deep vein thrombosis will also be assessed. |
| Measure | Description | Time Frame |
|---|---|---|
| Surgical site infection at the conduit harvest site | The ASEPSIS tool is a well established tool to quantify wound healing disturbances. | 30 days of CABG surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Ability to identify abnormal segments of vein on ultrasound and direct surgical excision away from such areas. | Applicable to the ultrasound imaged group only. The incidence of an abnormal segment of vein will be quantified and whether or not this has led to avoidance of unnecessary surgical excisions. | baseline |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Reshat Reshat, PhD | University Hospital Bristol NHS FT | Principal Investigator |
| Teresa Robinson, MSc | University Hospital Bristol NHS FT | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Bristol NHS FT | Bristol | BS2 8HW | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013530 | Surgical Wound Infection |
| ID | Term |
|---|---|
| D014946 | Wound Infection |
| D007239 | Infections |
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Time taken to harvest a suitable conduit. |
The time to harvest a suitable conduit will be recorded during CABG surgery. |
| intraoperative |
| Length of lower limb vein harvest wounds. | Length of conduit harvest wounds will be measured after surgery to the nearest centimetre. | 1 day Post-operation |
| Blood loss from the vein harvest wound | The blood loss from the conduit harvest wound(s) will be measured during surgery by weighing swabs. | intraoperative |
| Patient questionnaire to assess wound/scar satisfaction and complications. | An assessment of patient satisfaction and non-infective complications related to the conduit harvesting for CABG surgery. | 30 days from surgery |
| D013568 |
| Pathological Conditions, Signs and Symptoms |